Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-45,358
Closed -$14.8M 183
2025
Q4
$14.8M Sell
45,358
-1,907
-4% -$605K 0.1% 100
2025
Q3
$13.3M Sell
47,265
-10,668
-18% -$3.09M 0.08% 103
2025
Q2
$16.2M Sell
57,933
-1,098
-2% -$311K 0.12% 81
2025
Q1
$18.4M Sell
59,031
-7,343
-11% -$2.17M 0.18% 69
2024
Q4
$17.3M Sell
66,374
-10,240
-13% -$3.04M 0.14% 70
2024
Q3
$24.7M Buy
76,614
+1,793
+2% +$587K 0.23% 58
2024
Q2
$23.4M Buy
74,821
+23,155
+45% +$6.8M 0.21% 62
2024
Q1
$14.7M Buy
+51,666
New +$15.1M 0.1% 95

Other funds holding AMGN

Cathie Wood's AMGN Position: Q1 2026 in Review

Cathie Wood sold out of Amgen (AMGN) in Q1 2026, closing a stake of 45,358 shares — an estimated $14.8M sold.

Cathie Wood first reported a position in AMGN in Q1 2024 and held it in 8 quarters. The position peaked at $24.7M in Q3 2024. 3,142 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Cathie Wood reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • Cathie Wood sold 45,358 Amgen shares in Q1 2026, an estimated $14.8M.
  • Cathie Wood first reported a position in Amgen in Q1 2024 and held it in 8 quarters.
  • Cathie Wood's Amgen position peaked at $24.7M in Q3 2024.
  • 3,142 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on ARK Investment Management's 13F filing for Q1 2026, filed 12 May 2026.